Cormorant Asset Management, LP Closed Holding Positions

Cormorant Asset Management, LP

Stock	Closed Quarter	Shares Sold	Price Range
WVE Wave Life Sciences Ltd. Healthcare	Q1 2018 Filed on May 15, 2018	202,079	$32.45 - $54.7 $6.56M - $11.1M
SYRS Syros Pharmaceuticals, Inc. Healthcare	Q1 2018 Filed on May 15, 2018	296,296	$9.47 - $12.98 $2.81M - $3.85M
Oncobiologics Inc	Q1 2018 Filed on May 15, 2018	30,536	N/A
Proteostasis Therapeutics In	Q1 2018 Filed on May 15, 2018	3,300,000	N/A
OVID Ovid Therapeutics Inc. Healthcare	Q1 2018 Filed on May 15, 2018	223,972	$6.53 - $9.82 $1.46M - $2.2M
ARDX Ardelyx, Inc. Healthcare	Q1 2018 Filed on May 15, 2018	572,738	$5.05 - $7.9 $2.89M - $4.52M
Juno Therapeutics Inc	Q1 2018 Filed on May 15, 2018	550,000	N/A
Omeros Corp	Q4 2017 Filed on Feb 14, 2018	750,000	N/A
Alder Biopharmaceuticals Inc	Q4 2017 Filed on Feb 14, 2018	900,000	N/A
Portola Pharmaceuticals Inc	Q4 2017 Filed on Feb 14, 2018	500,000	N/A
Immune Design Corp	Q4 2017 Filed on Feb 14, 2018	280,500	N/A
Ignyta Inc	Q4 2017 Filed on Feb 14, 2018	3,500,000	N/A
Curis Inc	Q4 2017 Filed on Feb 14, 2018	1,150,000	N/A
Advanced Accelerator Applic	Q4 2017 Filed on Feb 14, 2018	75,000	N/A
NVRO Nevro Corp Healthcare	Q4 2017 Filed on Feb 14, 2018	100,000	$65.94 - $93.31 $6.59M - $9.33M
EGRX Eagle Pharmaceuticals, Inc. Healthcare	Q4 2017 Filed on Feb 14, 2018	200,000	$49.6 - $60.87 $9.92M - $12.2M
Agile Therapeutics Inc	Q4 2017 Filed on Feb 14, 2018	1,250,000	N/A

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.